4.04
Schlusskurs vom Vortag:
$4.19
Offen:
$4.29
24-Stunden-Volumen:
43,798
Relative Volume:
0.84
Marktkapitalisierung:
$12.20M
Einnahmen:
$2.38M
Nettoeinkommen (Verlust:
$-12.40M
KGV:
-0.6251
EPS:
-6.4626
Netto-Cashflow:
$-18.68M
1W Leistung:
-15.48%
1M Leistung:
-44.32%
6M Leistung:
-74.67%
1J Leistung:
-77.05%
Femasys Inc Stock (FEMY) Company Profile
Firmenname
Femasys Inc
Sektor
Telefon
770-500-3910
Adresse
3950 JOHNS CREEK COURT, SUWANEE
Compare FEMY vs ISRG, BDX, ALC, MDLN, RMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
FEMY
Femasys Inc
|
4.04 | 12.20M | 2.38M | -12.40M | -18.68M | -6.4626 |
|
ISRG
Intuitive Surgical Inc
|
406.78 | 144.07B | 10.58B | 3.00B | 2.83B | 8.2437 |
|
BDX
Becton Dickinson Co
|
143.98 | 39.67B | 21.37B | 1.41B | 3.07B | 3.9437 |
|
ALC
Alcon Inc
|
64.68 | 31.54B | 10.63B | 819.00M | 1.59B | 1.6577 |
|
MDLN
Medline Inc
|
35.94 | 30.39B | 29.14B | 1.07B | 1.05B | 1.1956 |
|
RMD
Resmed Inc
|
188.63 | 27.36B | 5.54B | 1.52B | 1.74B | 10.37 |
Femasys Inc Stock (FEMY) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-11-20 | Eingeleitet | Laidlaw | Buy |
Femasys Inc Aktie (FEMY) Neueste Nachrichten
Femasys, Inc. Stock Hits 52-Week Low at $4.50 Amid Challenges - MarketsMojo
Femasys, Inc. Stock Hits New 52-Week Low at $3.87 - Markets Mojo
Femasys Inc (FEMY) Valuation: PE, PB & Fair Value Analysis - TradingKey
Femasys Inc (FEMY) Institutional Confidence - TradingKey
Femasys Inc (FEMY) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Femasys Inc (FEMY) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Femasys Inc (FEMY) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Femasys, Inc. Stock Plummets to New 52-Week Low of $3.77 - Markets Mojo
Femasys Inc (FEMY) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Femasys Inc (FEMY) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
FEMY Stock Price, Quote & Chart - ChartMill
Femasys Inc. (FEMY) Q1 2026 Earnings: Narrower-than-Expected Loss Drives Positive SurpriseEarnings Revision Upgrade - newsline.com
Femasys Inc.: Target Price Consensus and Analysts Recommendations | FEMY | US31447E2046 - marketscreener.com
Femasys Inc.: Performance & Quotes, FEMY Stock Price on Nasdaq Exchange - marketscreener.com
Femasys Inc (FEMY) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Femasys Inc.: Fundamental Analysis and Financial Ratings | FEMY | US31447E2046 - marketscreener.com
Femasys Inc.: Financial Data Forecasts Estimates and Expectations | FEMY | US31447E2046 - marketscreener.com
FEMY Q1 2026 Earnings: EPS Surprises to the Upside as Narrower Loss Drives Stock HigherBalance Sheet Strength - newsline.com
Femasys Inc. (FEMY) Edges Higher as Stock Tests Key Resistance LevelsWMA Signal - newsline.com
Femasys, Inc. Hits New 52-Week Low at $5.08 Amid Market Challenges - MarketsMojo
Femasys Inc. (FEMY) Q1 2026 Earnings: EPS Surprises to the Upside Despite Stock DeclineEstimate Dispersion - newsline.com
Femasys Inc. (FEMY) Shares Decline 14% as Price Tests Support Near $0.29Dark Pool Prints - newsline.com
Femasys Announces 1-for-20 Reverse Stock Split Implementation - TipRanks
Femasys (NASDAQ: FEMY) implements 1-for-20 reverse stock split - Stock Titan
Femasys (FEMY) Slides 2.96% as Shares Test Key Support LevelVolume Spike Alerts - newsline.com
Femasys Announces 1-for-20 Reverse Stock Split Initiative - TipRanks
Femasys to implement 1-for-20 reverse stock split; trading symbol FEMY unchanged - TradingView
Reverse split will consolidate Femasys (NASDAQ: FEMY) common shares 20-to-1 - Stock Titan
Femasys, Inc. Financial Disclosures & SEC Filings - TradingView
Femasys Inc. (FEMY) Q1 2026 Earnings: Narrower-Than-Expected Loss Highlights Cost Discipline Amid Revenue UncertaintyRevenue Growth Report - newsline.com
FEMY Technical Analysis & Stock Price Forecast - Intellectia AI
Femasys Inc. (FEMY) Edges Higher as Key Support Holds at $0.37Technical Analysis Picks - The Legal Advocate
Femasys Inc. (FEMY) Q1 2026 Earnings: EPS Beat Drives 29.85% Stock SurgeMid-Term Outlook - newsline.com
Femasys Analyst Ratings and Price Targets | NASDAQ:FEMY - Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga
FEMY Technical Analysis | Trend, Signals & Chart Patterns | FEMASYS INC (NASDAQ:FEMY) - ChartMill
Maxim Group Maintains Femasys(FEMY.US) With Buy Rating, Maintains Target Price $1.5 - Moomoo
Femasys Expands Fertility Care Portfolio in Europe with CE Mark Approval for FemHSG™ Catheter - Sahm
Femasys updates corporate presentation on women’s health portfolio - The Globe and Mail
Femasys receives CE Mark approval for FemHSG fertility catheter - Investing.com UK
Maxim Group Maintains Femasys(FEMY.US) With Buy Rating, Cuts Target Price to $1.5 - Moomoo
Femasys posts updated corporate presentation detailing fertility and FemBloc commercialization plans - TradingView
Femasys (NASDAQ: FEMY) outlines FemaSeed fertility and FemBloc birth control strategy - Stock Titan
Femasys receives CE Mark approval for FemHSG fertility catheter By Investing.com - Investing.com South Africa
Lake Street Remains a Buy on Femasys (FEMY) - The Globe and Mail
Femasys Expands Fertility Care Portfolio In Europe With CE Mark Approval For Femhsg™ Catheter - TradingView
TradingKey - TradingKey
Femasys Reverse Stock Split May Not Prevent Nasdaq Delisting Risk, Observer Warns - The Globe and Mail
Femasys Inc. Announces Financial Results for Quarter Ending March 31, 2026 - geneonline.com
Femasys Inc. Q1 2026 Financials: Revenue Growth, Forward-Looking Statements, and Market Strategy - Minichart
Femasys Inc expected to post a loss of 9 cents a shareEarnings Preview - TradingView
Finanzdaten der Femasys Inc-Aktie (FEMY)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):